Wednesday, July 8, 2026

pharma · Acute Myeloid Leukemia · Advanced Hematologic Malignancy · FHTX

Foghorn Therapeutics

Foghorn Therapeutics trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Watertown, USA HQ
2016 Founded
124 Employees
Public company Type
FHTX · NYSE Ticker
Company details
Status
Public
HQ
Watertown, USA
Founded
2016
Employees
124
Programs
5
Drugs
2
Patents
14
Intelligence · Clinical Trials

Foghorn Therapeutics clinical trials

Registry index of 5 ClinicalTrials.gov studies linked to Foghorn Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Foghorn Therapeutics trial registry — 5 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

5 updates

Latest clinical program signals indexed for Foghorn Therapeutics.

  1. FHD-286 — Phase 1

    Clinical update
  2. FHD-286 — Phase 2

    Clinical update
  3. Decitabine — Phase 1

    Clinical update
  4. FHD-286 — Phase 1

    Clinical update
  5. FHD-609 — Phase 1

    Clinical update

Trial registry

5 studies